首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study
【24h】

Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study

机译:用生物DMARDS治疗类风湿性关节炎患者第二恶性肿瘤和死亡率的风险:丹麦人口群体研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective To study the risk of a second malignant neoplasm (SMN) and mortality in patients with rheumatoid arthritis (RA) with a history of a primary cancer diagnosis and treated with biological disease-modifying antirheumatic drugs (bDMARD).
机译:目的探讨具有类风湿性关节炎(RA)的第二次恶性肿瘤(SMN)和死亡率的风险,具有原发性癌症诊断的历史,并用生物疾病修饰的抗胃(BDMARD)治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号